Wei Li Email

Chief Scientific Officer . Cytovia Therapeutics

New York, NY

Location

Current Roles

Employees:
38
Revenue:
$2.9M
About
Cytovia is dedicated to the development of transformational cancer immunotherapies, addressing several of the most challenging unmet medical needs including the prevention of cancer relapse and metastasis. Cytovia focuses on Natural Killer (NK) cell biology and applies precision medicine tools to develop the right therapy for the right patient at the right stage of the disease. Cytovia has secured access to multiple advanced technologies, including allogeneic cell therapy, multispecific antibodies, and cytokines. Cytovia establishes development partnerships to accelerate time-to-market and commercialization alliances in order to optimize rapid adoption of its novel immunotherapies.
Cytovia Therapeutics Address
18851 NE 29th Ave
New York, NY
Cytovia Therapeutics Email

Past Companies

Cytovia TherapeuticsChief Scientific Officer
NAYA BiosciencesBoard Member
CytoLynx TherapeuticsBoard Member

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.